Head-to-head
Eden vs Hims & Hers
Eden and Hims & Hers both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
Eden
Higher scoreRanked #2 · Grade B+
Best for: Parents who want a transparent, well-run async program with both molecules and don't mind paying above the cheapest tiers for a tidy experience.
Visit EdenHims & Hers
Ranked #4 · Grade B+
Best for: Parents who want a recognizable, app-driven brand with a quick async signup and clear semaglutide pricing.
Visit Hims & HersThe verdict
Eden edges out Hims & Hers on the Rx-Readiness Score, 89 to 87 (B+ vs B+). Parents who want a transparent, well-run async program with both molecules and don't mind paying above the cheapest tiers for a tidy experience.
Hims & Hers is still a genuine option — a polished, app-first mass-market brand with a fast async funnel — dependable and familiar, though tirzepatide pricing isn't consistently posted. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Eden | Hims & Hers |
|---|---|---|
| Rx-Readiness Score | 89/100 · B+ | 87/100 · B+ |
| Overall rank | #2 | #4 |
| Semaglutide | $239/mo | $199/mo |
| Tirzepatide | $349/mo | Not disclosed |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Eden
Ranked #2 · Grade B+
What we like
- Clear flat pricing and a straightforward async signup — no drawn-out scheduling
- Both semaglutide and tirzepatide, available in all 50 states
- Strong up-front disclosure, so there are fewer surprises after you commit
The caveats
- Premium sticker price versus the budget tiers
- Compounded only — no brand-name lane
- No oral route for the needle-averse
Hims & Hers
Ranked #4 · Grade B+
What we like
- Slick app-first experience with a fast, mostly async intake
- Flat, posted semaglutide pricing and nationwide coverage
- Well-known operator with a mature support stack
The caveats
- Tirzepatide pricing isn't consistently disclosed up front
- Compounded only — no brand or oral route
- Upsells across a broad catalog can add noise to a simple decision
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing Eden and Hims & Hers against other providers on our shortlist.
Or browse the full comparison hub.